Intelligence Platform
Patents
Browse 8 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12162818
Inhibitors of the n-terminal domain of the androgen receptor
granted patentUS 12049486
PAC1 receptor agonists (MAXCAPs) and uses thereof
granted patentUS 11643656
Antisense therapies for treating cancer
granted patentUS 11274303
Olmalinc as a diagnostic and therapeutic target for NAFLD, NASH, metabolic syndrome, and h
granted patentUS 11236139
Combination immunotherapy
granted patentUS 11186622
PAC1 receptor agonists (MAXCAPS) and uses thereof
granted patentUS 10961301
Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair
granted patentUS 9272051
Methods and systems for modulating hormones and related methods, agents and compositions
granted